Recent Articles
- Pattern Awarded $22.5M BARDA Contract to Advance Single-Cell Microbiology System and Critical Care Antimicrobial Susceptibility Testing Panels for Pneumonia and Bacteremia
- Pattern Bioscience Selected as Winner of ADLM Disruptive Technology Award
- Pattern Bioscience Secures $28.7 Million in Series C Financing
- Pattern Bioscience Appoints Carey-Ann Burnham as Chief Clinical Officer
- Pattern Receives FDA “Breakthrough Device Designation” for Pneumonia Action Panel